Recently, the renin-angiotensin system (RAS) was implicated in organ fibrosis. However, few studies have examined the localization of RAS components, such as angiotensin II receptors, renin (REN), angiotensinogen (AGTN), and angiotensin-converting enzyme (ACE), in the fibrosing kidney. To localize these components in the fibrosing kidney, we used a murine model of renal fibrosis that shows an enhanced expression of angiotensin II type 1A receptor (AT 1A R) and AGTN. Our results indicate that the overall expression of angiotensin II type 2 receptor (AT 2 R) and ACE was attenuated in this model, whereas REN expression was unchanged. In addition to tubular epithelial cells that were positive for AT 1A The activation of angiotensin II receptors by angiotensin II has been reported to contribute to the progression of renal fibrosis. 1-3 The intrarenal renin-angiotensin system (RAS) was described in the 1980's, 4 and the kidney contains angiotensin II at a significantly higher level than serum. 5 Although the intrarenal RAS may be altered in some diseased states, 6 -12 the localization of each component of the RAS, such as angiotensin II type 1 and type 2 receptors (AT 1 R and AT 2 R), renin (REN), angiotensinogen (AGTN), and angiotensin-converting enzyme (ACE), in the fibrosing kidney is undefined. In this study, we use immunocytochemical analysis and in situ hybridization techniques to identify cells expressing the RAS components in a murine model of advanced interstitial fibrosis of the kidney.
Materials and Methods
Murine Model of Renal FibrosisWe used 5-week-old mice that are transgenic for transforming growth factor (TGF)-1 13 and that had undergone a subtotal nephrectomy as a model of renal fibrosis. These mice reproducibly develop significant interstitial fibrosis at 12 weeks after surgery. Sham-operated TGF-1 transgenic mice were used as controls. We confirmed that the control transgenic mice did not show any significant fibrosis in the kidney by 17 week of age. After 17 weeks, the control mice randomly develop renal fibrosis. At 12 weeks after renoablation, half of each kidney was fixed using 4% paraformaldehyde in phosphatebuffered saline overnight. A portion of each fixed specimen was processed into paraffin blocks for histopathology. The rest of the fixed tissue was rinsed in serial concentrations of sucrose, and then snap-frozen in preparation for immunostaining and in situ hybridization. Total RNA was extracted from the homogenates of the other half of each kidney using TRIzol (Life Technologies, Inc., Grand Island, NY) according to the manufacturer's instructions.